Tonix Pharmaceuticals stock halted ahead of FDA approval news
HONOLULU - Orthogonal Thinker, Inc. announced Tuesday it plans to acquire and fully consolidate Ei.Ventures, Inc., its majority-owned subsidiary, in a transaction expected to complete by the end of Q1 2026.
The consolidation represents a strategic move to streamline Orthogonal’s corporate structure and align investor interests across its portfolio. Under the terms of the agreement, all minority shareholders of Ei.Ventures will receive equity in Orthogonal Thinker, with the final exchange ratio to be disclosed in formal offer documents expected in October 2025.
Orthogonal indicated the transaction will include a premium above relative valuation for Ei.Ventures shareholders. The company stated the consolidation does not require a shareholder vote unless mandated by applicable law.
"We are not exiting—we’re doubling down," said David Nikzad, Founder of Orthogonal Thinker, in the press release statement.
Both companies hold significant equity positions in Cloud3 Ventures Inc. (CSE:CVC) (OTCQB:CLVLF), a company currently valued at $394.33M with impressive gross profit margins of ~91% and strong financial health metrics, though no immediate changes regarding these holdings were announced. According to InvestingPro analysis, CLVLF is currently trading below its Fair Value.
Ei.Ventures was founded in 2020 to focus on psychedelic and plant-based science for health and wellness applications. Orthogonal Thinker, established in 2016, operates as an integrated holding company investing in companies across plant sciences, sustainable energy, nutrition, and technology sectors.
The announcement comes as Orthogonal seeks to position itself for what it describes as improving market conditions, with the transaction representing a key step in its multi-year strategic plan. With Cloud3 Ventures’ next earnings report due August 29, 2025, InvestingPro subscribers can access 8 additional key insights and detailed financial metrics to evaluate this strategic move’s potential impact.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.